Skip to main content
Journal cover image

Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.

Publication ,  Journal Article
Samsky, MD; Hellkamp, A; Hiatt, WR; Fowkes, FGR; Baumgartner, I; Berger, JS; Katona, BG; Mahaffey, KW; Norgren, L; Blomster, JI; Rockhold, FW ...
Published in: J Am Heart Assoc
June 15, 2021

Background Peripheral artery disease (PAD) and heart failure (HF) are each independently associated with poor outcomes. Risk factors associated with new-onset HF in patients with primary PAD are unknown. Furthermore, how the presence of HF is associated with outcomes in patients with PAD is unknown. Methods and Results This analysis examined risk relationships of HF on outcomes in patients with symptomatic PAD randomized to ticagrelor or clopidogrel as part of the EUCLID (Examining Use of Ticagrelor in Peripheral Arterial Disease) trial. Patients were stratified based on presence of HF at enrollment. Cox models were used to determine the association of HF with outcomes. A separate Cox model was used to identify risk factors associated with development of HF during follow-up. Patients with PAD and HF had over twice the rate of concomitant coronary artery disease as those without HF. Patients with PAD and HF had significantly increased risk of major adverse cardiovascular events (hazard ratio [HR], 1.31; 95% CI, 1.13-1.51) and all-cause mortality (HR, 1.39; 95% CI, 1.19-1.63). In patients with PAD, the presence of HF was associated with significantly less bleeding (HR, 0.65; 95% CI, 0.45-0.96). Characteristics associated with HF development included age ≥66 (HR, 1.29; 95% CI, 1.18-1.40 per 5 years), diabetes mellitus (HR, 1.85; 95% CI, 1.41-2.43), and weight (bidirectionally associated, ≥76 kg, HR, 0.77; 95% CI, 0.64-0.93; <76 kg, HR, 1.12; 95% CI, 1.07-1.16). Conclusions Patients with PAD and HF have a high rate of coronary artery disease with a high risk for major adverse cardiovascular events and death. These data support the possible need for aggressive treatment of (recurrent) atherosclerotic disease in PAD, especially patients with HF.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

June 15, 2021

Volume

10

Issue

12

Start / End Page

e018684

Location

England

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Ticagrelor
  • Risk Factors
  • Risk Assessment
  • Randomized Controlled Trials as Topic
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Peripheral Arterial Disease
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Samsky, M. D., Hellkamp, A., Hiatt, W. R., Fowkes, F. G. R., Baumgartner, I., Berger, J. S., … Jones, W. S. (2021). Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. J Am Heart Assoc, 10(12), e018684. https://doi.org/10.1161/JAHA.120.018684
Samsky, Marc D., Anne Hellkamp, William R. Hiatt, F Gerry R. Fowkes, Iris Baumgartner, Jeffrey S. Berger, Brian G. Katona, et al. “Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.J Am Heart Assoc 10, no. 12 (June 15, 2021): e018684. https://doi.org/10.1161/JAHA.120.018684.
Samsky MD, Hellkamp A, Hiatt WR, Fowkes FGR, Baumgartner I, Berger JS, et al. Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. J Am Heart Assoc. 2021 Jun 15;10(12):e018684.
Samsky, Marc D., et al. “Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.J Am Heart Assoc, vol. 10, no. 12, June 2021, p. e018684. Pubmed, doi:10.1161/JAHA.120.018684.
Samsky MD, Hellkamp A, Hiatt WR, Fowkes FGR, Baumgartner I, Berger JS, Katona BG, Mahaffey KW, Norgren L, Blomster JI, Rockhold FW, DeVore AD, Patel MR, Jones WS. Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. J Am Heart Assoc. 2021 Jun 15;10(12):e018684.
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

June 15, 2021

Volume

10

Issue

12

Start / End Page

e018684

Location

England

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Ticagrelor
  • Risk Factors
  • Risk Assessment
  • Randomized Controlled Trials as Topic
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Peripheral Arterial Disease
  • Middle Aged